| Description | It is a human antibody which targets haemophilus influenzae type b capsular polysaccharide (Hib PS). It has inhibiting potency against Hib PS. It also cross-reacted with capsular PS of the K100 serotype of E. coli. This product has been detected by Enzyme-linked immunosorbent assay, Inhibition assay and other applications. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Haemophilus influenzae Type b (Hib) |
| Cross Reactivity | E. coli K100 |
| Immunogen | Hib oligosaccharide CRM197 mutant Corynebacterium diphtheriae protein conjugate vaccine |
| Isotype | IgG1, kappa |
| Expression Species | HEK293F or CHO cell |
| Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
| Endotoxin | <1 EU/mg |
| Form | Liquid |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
| Application | ELISA; Inhib |
| Application Notes | The Hib PS-inhibitable mAbs from infants cross-reacted with E. coli K100 PS. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | Hib PS |
| Alternative Name | Haemophilus influenzae type b bacterial polysaccharides |
| Research Area | Infectious Disease |
| Related Disease | Influenza |
